期刊文献+

老年特发性血小板减少性紫癜临床及疗效的回顾性分析 被引量:2

原文传递
导出
摘要 特发性血小板减少性紫癜(ITP)是一种免疫介导的以血小板减少为主要临床表现的自身免疫性疾病,是临床最为常见的出血性疾病之一,约占出血性疾病的30%。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2010年第5期333-335,共3页 Chinese Journal of Hematology
基金 基金项目:国家自然科学基金(30600259、30600680、30770922、30570779) 国家"973"项目(2006 CB 50503803) 教育部全国优秀博士论文专项基金(200561) 新世纪优秀人才支持计划(NCET-07-0514) 教育部科学技术研究重点项目(109097) 卫生部临床学科重点项目(2007-2009) 国家卫生行业公益性科研专项(200802031) 教育部科技创新工程重大项目培育资金项目(N0704030) 泰山学者岗位基金 山东省中医药科技发展计划(2005-049)
  • 相关文献

参考文献3

二级参考文献6

  • 1秦平,陈峰,张春青,彭军,陈学良,侯明.大剂量地塞米松治疗慢性特发性血小板减少性紫癜的疗效观察[J].中华内科杂志,2005,44(6):451-452. 被引量:46
  • 2British Committee for Standerds in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol, 2003,120,574-596.
  • 3Stasi R, Brunetti M, Pagano A, et al. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Blood Cells Mol Dis, 2000, 26:582-586.
  • 4Wali YA, AL Lamki, Shah W, et al. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol, 2002, 19:329-335.
  • 5Cheng Y, Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-Dose dexamethasone. N Engl J Med, 2003,349: 831-836.
  • 6周建国.老年前期及老年人原发性血小板减少性紫癜...[J].中华老年医学杂志,1992,11(5):278-280. 被引量:4

共引文献60

同被引文献19

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 2吕洁清,聂大年,谢双锋,尹松梅.成人特发性血小板减少性紫癜102例临床分析[J].实用医学杂志,2004,20(9):1052-1054. 被引量:8
  • 3Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 2009, 113(11) :2386-2393.
  • 4Strohsnitter WC, Noller KL, Troisi R, et al. Autoimmune dis- ease incidence among women prenatally exposed to diethyl- stilbestrol. J Rheumatol, 2010, 37(10) :2167-2173.
  • 5Neylon AJ,Saunders PW,Howard MR,et al.Clinically signifi- cant newly presenting autoinunune thrombocytopenc purpura in aduhs:a prospective study of a population-based cohort of 245 patients.Br J Haematol, 2003, 122(9) : 966-974.
  • 6segal JB,Powe NR.Prevalence of immune thrombocytopenia: analyses of administrative data.J Thromb Haemost,2006, 86 (23) : 2377-2383.
  • 7Bizzoni L,Mazmcconi MG,Gentile M,et al. Idiopathic throm- bocytopenic purpura(ITP) in the elderly:clinical course in 178 patients. Eur J Haematol, 2006, 7(9):210-216.
  • 8Daou S, Federici L, Zimmer J, et al. Idiopathic thrombocy- topenic purpura in elderly patients: a study of 47 cases from a single reference center. Eur J Intern Med, 2008, 19(2) :447-451.
  • 9Zeng QS, Zhu LY, Tao LL, et al. Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIb~ antibodies. Am J Hematol, 2012, 87 (2) :206-208.
  • 10Andrb E,Zimmer J,Noel E,et al.Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids,splenectomy and danazol. Drugs Aging, 2003, 20(6) : 841-846.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部